These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. The psychopharmacology of obsessive compulsive disorder. Implications for treatment and pathogenesis. McDougle CJ; Goodman WK; Leckman JF; Price LH Psychiatr Clin North Am; 1993 Dec; 16(4):749-66. PubMed ID: 8309811 [TBL] [Abstract][Full Text] [Related]
4. Desensitization of terminal 5-HT autoreceptors by 5-HT reuptake blockers. de Montigny C; Blier P Arch Gen Psychiatry; 1991 May; 48(5):483-4. PubMed ID: 2021304 [No Abstract] [Full Text] [Related]
5. [Monoamine oxidase inhibitors in the treatment of obsessive disorders. Two case reports and review of the literature]. Erfurth A; Schmauss M Nervenarzt; 1993 Jan; 64(1):70-2. PubMed ID: 8437650 [TBL] [Abstract][Full Text] [Related]
6. Fluvoxamine versus clomipramine in the treatment of obsessive compulsive disorder: a multicenter, randomized, double-blind, parallel group comparison. Freeman CP; Trimble MR; Deakin JF; Stokes TM; Ashford JJ J Clin Psychiatry; 1994 Jul; 55(7):301-5. PubMed ID: 8071291 [TBL] [Abstract][Full Text] [Related]
7. Effectiveness of paroxetine in the treatment of obsessive-compulsive disorders. Kamijima K; Aoki M Expert Rev Neurother; 2006 Jul; 6(7):945-56. PubMed ID: 16831110 [TBL] [Abstract][Full Text] [Related]
9. Clomipramine treatment of obsessive compulsive symptomatology in schizophrenic patients. Zohar J; Kaplan Z; Benjamin J J Clin Psychiatry; 1993 Oct; 54(10):385-8. PubMed ID: 7903293 [TBL] [Abstract][Full Text] [Related]
10. Moclobemide response in obsessive-compulsive disorder. al Jeshi A Can J Psychiatry; 1999 Apr; 44(3):285. PubMed ID: 10225134 [No Abstract] [Full Text] [Related]
11. Lack of efficacy of low doses of quetiapine addition in refractory obsessive-compulsive disorder. Sevincok L; Topuz A J Clin Psychopharmacol; 2003 Oct; 23(5):448-50. PubMed ID: 14520120 [TBL] [Abstract][Full Text] [Related]
12. Therapeutic applications and mechanisms of action of monoamine oxidase inhibitor and heterocyclic antidepressant drugs. Goodman WK; Charney DS J Clin Psychiatry; 1985 Oct; 46(10 Pt 2):6-24. PubMed ID: 3900056 [TBL] [Abstract][Full Text] [Related]
13. Test of dopamine-blocking potential of clomipramine. Kim SW; Dysken MW Am J Psychiatry; 1991 May; 148(5):690. PubMed ID: 2018183 [No Abstract] [Full Text] [Related]
14. Obsessive-compulsive disorder and its treatment with serotonin-selective agents. Murphy DL; Pigott TA Prog Clin Biol Res; 1990; 361():179-201. PubMed ID: 2290841 [No Abstract] [Full Text] [Related]